Patents by Inventor Geert Mudde

Geert Mudde has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8921279
    Abstract: The present invention relates to a method of preparing a genetic package displaying oligomers of modular antibody domains binding to a target and to a scaffold ligand as well as to vectors and libraries of genetic packages produced thereby. The invention further relates to methods of selecting suitable linker sequences for use in such oligomer display.
    Type: Grant
    Filed: June 26, 2008
    Date of Patent: December 30, 2014
    Assignee: F-Star Biotechnologische Forschungs—und Entwicklungsges. m.b.H
    Inventors: Gottfried Himmler, Florian Ruker, Gerda Redl, Gordana Wozniak-Knopp, Geert Mudde
  • Publication number: 20140364592
    Abstract: The invention relates to a cytotoxic modular antibody with a molecular weight of up to 6OkD, specifically binding to a cell surface target with a binding affinity of Kd<10?8 M, a method of producing such antibody and its use as a therapeutic.
    Type: Application
    Filed: August 27, 2014
    Publication date: December 11, 2014
    Inventors: Gottfried Himmler, Geert Mudde, Anton Bauer, Gerda Redl, Maximillian Woisetschlager
  • Patent number: 8859738
    Abstract: The invention relates to a cytotoxic modular antibody with a molecular weight of up to 6 OkD, specifically binding to a cell surface target with a binding affinity of Kd<10?8 M, a method of producing such antibody and its use as a therapeutic.
    Type: Grant
    Filed: March 3, 2009
    Date of Patent: October 14, 2014
    Assignee: F-Star Biotechnologische Forschungs- und Entwicklungsges. M.B.H
    Inventors: Gottfried Himmler, Geert Mudde, Anton Bauer, Gerda Redl, Maximillian Woisetschlager
  • Publication number: 20130243767
    Abstract: A molecule or molecule complex capable of binding to TLR9 and to CD32 comprising at least one epitope of at least one antigen, and its use a medicament for the treatment of allergies.
    Type: Application
    Filed: March 8, 2013
    Publication date: September 19, 2013
    Inventor: Geert Mudde
  • Publication number: 20110046355
    Abstract: The invention relates to a cytotoxic modular antibody with a molecular weight of up to 6 OkD, specifically binding to a cell surface target with a binding affinity of Kd<10?8 M, a method of producing such antibody and its use as a therapeutic.
    Type: Application
    Filed: March 3, 2009
    Publication date: February 24, 2011
    Inventors: Gottfried Himmler, Geert Mudde, Anton Bauer, Gerda Redl
  • Publication number: 20100184615
    Abstract: The present invention relates to a method of preparing a genetic package displaying oligomers of modular antibody domains binding to a target and to a scaffold ligand as well as to vectors and libraries of genetic packages produced thereby. The invention further relates to methods of selecting suitable linker sequences for use in such oligomer display.
    Type: Application
    Filed: June 26, 2008
    Publication date: July 22, 2010
    Inventors: Gottfried Himmler, Florian Ruker, Gerda Redl, Gordana Wozniak-Knopp, Geert Mudde
  • Publication number: 20100143342
    Abstract: A molecule or molecule complex capable of binding to TLR9 and to CD32 comprising at least one epitope of at least one antigen, its production and its use a medicament, especially for the treatment of allergies.
    Type: Application
    Filed: February 28, 2007
    Publication date: June 10, 2010
    Applicant: F-STAR BIOTECHNOLOGISCHE FORSCHUNGS-UND ENTWICKLUNGSGES. M.B.H.
    Inventors: Geert Mudde, Gottfried Himmler